Moon Soo Kim

Moon Soo Kim

Auto-generated profile, based on publicly available information

Moon Soo Kim

Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2020 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
HYHee Chul Yang
Hee Chul Yang
JCJin-Ho Choi
Jin-Ho Choi
MKMoon Soo Kim
Moon Soo Kim
JLJong Mog Lee
Jong Mog Lee
Hee Chul Yang, M.D., Ph.D., Jin Ho Choi, M.D., Moon Soo Kim, M.D., Jong Mog Lee, M.D.. Korean J Thorac Cardiovasc Surg 2020;53:226-32. https://doi.org/10.5090/kjtcs.2020.53.4.226


3 April 2023 in Chest
Verified
Journal Article
Open access
PDF file
HCHyun Sung Chung
Hyun Sung Chung
HYHo Il Yoon
Ho Il Yoon
BHBin Hwangbo
Bin Hwangbo
EPEun Young Park
Eun Young Park
CCChang-Min Choi
Chang-Min Choi
JLJong Mog Lee
Jong Mog Lee
Background Prediction models for mediastinal metastasis and its detection by endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) have not been developed using a prospective cohort of potentially operable non-small cell lung cancer (NSCLC) patients. Research Question Can mediastinal metastasis and its detection by EBUS-TBNA be predicted with prediction models in NSCLC? Study Design and Methods For the prospective development cohort, 589 potentially operable NSCLC patients were evaluated (July 2016-June 2019) from 5 Korean teaching hospitals. Mediastinal staging was performed using EBUS-TBNA (± trans-esophageal approach). Surgery was performed for patients without cN2-3 disease by endoscopic staging. The Prediction model for Lung cancer Staging-Mediastinal metastasis (PLUS-M) and a model for mediastinal metastasis detection by EBUS-TBNA (PLUS-E) were developed using multivariable logistic regression analyses. Validation was performed using a retrospective cohort (n=309) from a different time period (June 2019-August 2021). Results The prevalence of mediastinal metastasis diagnosed by EBUS-TBNA plus surgery and the sensitivity of EBUS-TBNA in the development cohort were 35.3% and 87.0%, respectively. In PLUS-M, younger age ( 3-5 cm) and cN1 or cN2-3 stage by CT or PET-CT were significant risk factors for N2-3 disease. Areas under the receiver operating characteristic curves (AUCs) for PLUS-M and PLUS-E were 0.876 (95% CI, 0.845–0.906) and 0.889 (95% CI, 0.859–0.918), respectively. Model fit was good (PLUS-M: Homer-Lemeshow P=0.658, Brier score=0.129; PLUS-E: Homer-Lemeshow P=0.569, Brier score=0.118). In the validation cohort, PLUS-M (AUC, 0.859 [95% CI, 0.817-0.902], Homer-Lemeshow P=0.609, Brier score=0.144) and PLUS-E (AUC, 0.900 [95% CI, 0.865-0.936], Homer-Lemeshow P=0.361, Brier score=0.112) showed good discrimination ability and calibration. Interpretation PLUS-M and PLUS-E can be effectively used for decision making for invasive mediastinal staging in NSCLC.

9 February 2022 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
HYHee Chul Yang
Hee Chul Yang
SCSeung Hyun Chung
Seung Hyun Chung
JYJi Sung Yoo
Ji Sung Yoo
BPBoram Park
Boram Park
MKMoon Soo Kim
Moon Soo Kim
PHPh.D.
Ph.D.
Hee Chul Yang, M.D., Ph.D., Seung Hyun Chung, M.D., Ph.D., Ji Sung Yoo, M.D., Ph.D., Boram Park, Ph.D., Moon Soo Kim, M.D., Jong Mog Lee, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.21.138

1 January 2022 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
HYHee Chul Yang
Hee Chul Yang
MKMoon Soo Kim
Moon Soo Kim
JLJong Mog Lee
Jong Mog Lee
JCJin-Ho Choi
Jin-Ho Choi
SPSang-Yoon Park
Sang-Yoon Park
Yang HC, et al. J Gynecol Oncol. 2021 Oct;33(1):e6. https://doi.org/10.3802/jgo.2022.33.e6